Journal Article Summary

The article investigates the effects of Buspirone on central sleep apnea (CSA) in individuals with chronic spinal cord injury (SCI). CSA is a condition where breathing repeatedly stops and starts during sleep, and those with SCI are at a higher risk for this disorder. Understanding how medications like Buspirone can influence CSA is important, as it may lead to better management strategies for patients suffering from sleep-disordered breathing.

In the study, eight men with chronic SCI and sleep-disordered breathing participated in a single-blind crossover trial. Over 13 days, they were given either Buspirone, Trazodone, or a placebo, with a washout period in between. The researchers measured various respiratory parameters, including the ability to tolerate carbon dioxide (CO2) levels. The results showed that Buspirone significantly widened the CO2 reserve and reduced the sensitivity to changes in CO2 compared to both Trazodone and placebo, suggesting that it may help decrease the risk of CSA in these patients.

However, the study has limitations, including a small sample size and the fact that it only included male participants, which may affect the generalizability of the findings. Patients should be cautious and consult their healthcare providers before considering Buspirone or any other medication for sleep apnea, especially given the complexities of managing sleep-disordered breathing in those with spinal cord injuries. Discussing treatment options and potential side effects with a healthcare professional is crucial for ensuring safety and effectiveness.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Maresh Scott, Prowting Joel, Vaughan Sarah, Kruppe Elizabeth, Alsabri Bander, Yarandi Hossein, Badr M. Safwan, Sankari Abdulghani. Buspirone decreases susceptibility to hypocapnic central sleep apnea in chronic SCI patients. Journal of Applied Physiology 2020. DOI: 10.1152/japplphysiol.00435.2020. PMID: 32816639. PMCID: PMC7654694.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]